Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BCR-ABL-IN-1 is a BCR-ABL tyrosine kinase inhibitor (pIC50: 6.46) and may be used in the research of chronic myelogenous leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BCR-ABL-IN-1 is a BCR-ABL tyrosine kinase inhibitor (pIC50: 6.46) and may be used in the research of chronic myelogenous leukemia. |
Targets&IC50 | BCR-ABL:6.46(pIC50) |
Molecular Weight | 459.44 |
Formula | C23H21F4N5O |
CAS No. | 188260-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BCR-ABL-IN-1 188260-50-6 Angiogenesis Cytoskeletal Signaling Tyrosine Kinase/Adaptors Bcr-Abl BCR ABL IN 1 BCRABLIN1 inhibitor inhibit